| Literature DB >> 22974783 |
Jared D Christensen1, Edward F Patz.
Abstract
Imaging continues to play an essential role in evaluating patients with lung cancer. Improvement in radiologic techniques will produce more accurate diagnostic information, but complementing conventional studies with molecular diagnostics will likely have an even greater impact on patient management. Integration of imaging studies and biomarkers into the diagnostic evaluation of patients with lung cancer provides an opportunity to more efficiently guide diagnosis, staging, treatment, and follow-up.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22974783 DOI: 10.1016/j.rcl.2012.06.002
Source DB: PubMed Journal: Radiol Clin North Am ISSN: 0033-8389 Impact factor: 2.303